Tennessee law could reduce delays for approved treatments | Opinion

ICLG · 5 hours ago Biotech

Delaware court throws out biotech IPO derivative suit

Delaware court throws out biotech IPO derivative suit  ICLG

#Biotech Headlines

BioSpace · 5 hours ago Biotech

Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.

Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.  BioSpace

#Clinical Trials

TheStreet Pro · 6 hours ago Biotech

Mag 7 Action Improves, But Biotech Keeps Delivering the Real Wins

Mag 7 Action Improves, But Biotech Keeps Delivering the Real Wins  TheStreet Pro

#Biotech Headlines

PR Newswire · 6 hours ago Biotech

Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease

Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease  PR Newswire

#Clinical Trials

PR Newswire · 7 hours ago Biotech

Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.

Cytonics Completes First-In-Human Phase 1 Clinical Study Report for CYT-108, Advancing Program Toward Next Phase of Development.  PR Newswire

#Clinical Trials

Reuters · 7 hours ago Biotech

EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials

EXCLUSIVE: US House committee opens investigation into Merck, AbbVie China drug trials  Reuters

#Clinical Trials